Under the agreement, Broadlane clients will have access to Integra products for the management of hydrocephalus, backed by Integra sales support. Broadlane clients include more than 1,100 acute-care hospitals and 50,000 non-acute care facilities across the United States.
Read the Integra LifeSciences release about the contract with The Broadlane Group.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences to Feature Total Wrist Fusion System for Arthritis Treatment
– Integra LifeSciences Receives FDA Clearance for ALIF Device
– Integra LifeSciences Introduces New Retraction System for Minimally Invasive Spine Surgery
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
